ClinicalTrials.gg
CompletedNCT07883434Updated Oct 20, 2026

Effects of Adding Motor Imagery Training to Exercise on Pain, Fibromyalgia Impact, and Kinesiophobia in Women With Fibromyalgia: a Randomized Controlled Trial

An observational study in Pain Management, Fibromyalgia and Imagery, Psychotherapy, sponsored by Ufuk University. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-20.

Sponsored by Ufuk University · Observational

Updated Oct 20, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
100
Ages
18 Years to 65 Years
Sex
Female
01

Study summary

Aim: To evaluate the effects of adding motor imagery training to exercise on pain, fibromyalgia impact, and kinesiophobia in women with fibromyalgia, and compare imagery ability and kinesiophobia with healthy volunteers.

Methods: In this randomized controlled study, 100 women with fibromyalgia were allocated to exercise alone (n=50) or exercise plus motor imagery training (n=50) for one month. Forty-five healthy volunteers provided baseline comparisons. Outcomes included Visual Analog Scale (VAS) pain and global assessment, Revised Fibromyalgia Impact Questionnaire (FIQR), and Tampa Scale of Kinesiophobia (TSK). Baseline imagery ability was assessed using the Kinesthetic and Visual Imagery Questionnaire-20.

02

Conditions studied

  • Pain Management
  • Fibromyalgia
  • Imagery, Psychotherapy
03

In context

Agnosia

1,269 studies on the registry are indexed under Agnosia; 524 are open to participants now.

This study's enrollment of 100 is below the median of 119 across 158 observational studies indexed under Agnosia.

Browse Agnosia studies →

Lead sponsor

Ufuk University is the lead sponsor of 41 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

100 female patients aged 18-65 years diagnosed with fibromyalgia according to the American College of Rheumatology (ACR) 2016 Fibromyalgia diagnostic criteria between May 1, 2021 and May 1, 2026

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Being between the ages of 18 and 65
  2. Having received a diagnosis of fibromyalgia according to the American College of Rheumatology (ACR) 2016 fibromyalgia diagnostic criteria

Exclusion criteria

Exclusion Criteria:

  1. Being under the age of 18 or over the age of 65
  2. Having a history of severe systemic, neurological, or psychiatric disease
  3. Having difficulty comprehending given instructions
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
100 participants (actual)
Target follow-up
1 Month
Patient registry
Yes

Interventions

  • OtherMotor imagery

    In the motor imagery training group, an experienced physiotherapist additionally provided motor imagery training comprising internal visual imagery (mentally simulating the visual image of the relevant movement), external visual imagery (performing the relevant movement in front of a mirror), and kinesthetic imagery (mentally simulating the sensation of the relevant movement). During motor imagery training, patients were asked to close their eyes and focus on the training in a quiet environment. During kinesthetic imagery, participants were asked to sense their body parts and mentally simulate the sensation of the relevant movement without any physical body movement. During the visual imagery process, participants watched a standard video recording of the exercises, after which they were asked to mentally simulate a visual representation of the movement without any physical body movement. In addition, patients were asked to perform the relevant movement in front of a mirror.

06

What researchers measure

Primary outcomes

  1. 0-10 cm Visual Analog Scale pain intensity

    Time frame: 1 month

  2. 0-10 cm Visual Analog Scale global self-assessment

    Time frame: 1 month

  3. Revised Fibromyalgia Impact Questionnaire score

    The Revised Fibromyalgia Impact Questionnaire (FIQR) is a questionnaire designed to assess functional limitations and disabilities resulting from fibromyalgia. The questionnaire comprises a total of 21 questions divided into three sections: function, overall impact, and symptoms. Responses to each question are indicated on a scale ranging from 0 to 10. Elevated scores signify a greater fibromyalgia-associated impairment

    Time frame: 1 month

  4. Tampa Scale of Kinesiophobia

    The Tampa Scale of Kinesiophobia is a 17-item self-report scale that assesses fear of movement and re-injury related to pain. Items are scored on a four-point Likert scale, ranging from 1 (strongly disagree) to 4 (strongly agree). The total score ranges from 17 to 68, with higher scores indicating a higher level of kinesiophobia

    Time frame: 1 month

07

Study locations

1 site
  • Ufuk University
    Ankara, Ankara 6520, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 20, 2026
Show all 1 update
  1. Oct 20, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07883434
Lead sponsor
Ufuk University
Responsible party
Elzem Bolkan Günaydın (Assoc. Prof. MD., Ufuk University) — Principal investigator
First posted
Oct 20, 2026
Start date
May 1, 2021
Primary completion
May 1, 2026
Completion
May 1, 2026
Last update
Oct 20, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion